Inflammatory Bowel Diseases Clinical Trial
Official title:
Surgery Versus Laser Ablation of Anal Diseases in Inflammatory Bowel Disease Patients
Verified date | May 2024 |
Source | Zagazig University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized comparative clinical trial carried out to compare between laser ablation and surgery in treating anal diseases in inflammatory bowel diseases patients and find out if one is superior to the other. Inflammatory bowel diseases patients with anal problems were divided into 2 groups, one group had traditional surgery and the other had laser ablation for anal diseases and results were compared between the 2 groups.
Status | Completed |
Enrollment | 108 |
Est. completion date | April 5, 2024 |
Est. primary completion date | April 5, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patients with history of inflammatory bowel disease ( non specific colitis, crohn's disease, ulcerative colitis). - Patients who accidently discovered to have inflammatory bowel disease. - Age group between 18 to 60 years old Exclusion Criteria: - Informed consent refusal. - Proved malignancy in inflammatory bowel disease patients - Patients less than 18 years old or more than 60 years old - Contraindications to general and spinal anesthesia - other types of colitis as ischemic colitis, pseudo-membranous colitis, infective colitis |
Country | Name | City | State |
---|---|---|---|
Egypt | Zagazig University Hospitals | Zagazig |
Lead Sponsor | Collaborator |
---|---|
Zagazig University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Operation time | operation time in minutes was studied between the 2 groups | Intraoperative (from skin incision to wound dressing.) | |
Primary | operative bleeding | bleeding in cc was calculated between the 2 groups | Intraoperative to 2 weeks after operation. | |
Primary | post operative anal discharge | presence of post operative anal discharge was detected in the 2 groups | from incision to 2 weeks after operation. | |
Primary | pain score with visual analogue scale | pain score with visual analogue scale was studied between the 2 groups,minimum score is 0 which means painless and maximum score is 10 which means very painful | from the 1st day to 2 weeks postoperatively | |
Primary | Healing time | time for complete healing after operation was studied between the 2 groups | healing time was studies from the 1st day to 3 months after operation | |
Primary | Return to work | Return to work after operation was studied between the 2 groups | Return to work was assessed from one day to 2 months after surgery | |
Primary | patient satisfaction score | patient satisfaction score among patients in the 2 groups was studied using customer satisfaction score, minimum score is 1 means very dissatisfied and maximum score is 10 means very satisfied | from one day to 3 months after operation | |
Primary | Recurrence | recurrence between 2 groups was assessed | detection of recurrence from 3 to 6 months after operation | |
Primary | Fistula occurence | fistula occurence studied between the 2 groups | from 2 weeks to 2 months after operation | |
Primary | Stenosis | post operative stenosis between the 2 groups was studied | stenosis was detected from wound healing to 6 months later | |
Primary | Discharge from hospital | hospital stay studied between the 2 groups | from one day post operative to one week | |
Secondary | age | age in the 2 groups was studied | age of participants was recorded for one year duration of the study | |
Secondary | sex | sex was studied in the 2 groups | sex of participants was recorded for one year duration of the study | |
Secondary | specific disease | diagnosis of crohn's disease, ulcerative colitis, non specific colitis by colonoscopy and biopsy was done in the 2 groups | diagnosis of diseases known 2 days before surgery from history |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Active, not recruiting |
NCT04989907 -
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Active, not recruiting |
NCT04990258 -
A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
|
||
Enrolling by invitation |
NCT06015789 -
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
|
||
Recruiting |
NCT06065995 -
StoMakker Mobile Application
|
N/A | |
Recruiting |
NCT03282786 -
Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease
|
N/A | |
Recruiting |
NCT06002074 -
SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT04960826 -
Study of an Environmental Risk Factor in Crohn's Disease
|
||
Recruiting |
NCT05413941 -
Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Completed |
NCT00721812 -
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
|
Phase 1 | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Recruiting |
NCT04991324 -
Cholecalciferol Comedication in IBD - the 5C-study
|
Phase 3 | |
Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
Not yet recruiting |
NCT05043818 -
A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
|
||
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT02874365 -
Intestinal Stem Cells Characterization
|
N/A | |
Not yet recruiting |
NCT02858557 -
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
|
N/A |